ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive: In their meta-analysis, Barratt et al. found that while the ABCG2 421C>A (Q141K, rs2231142) variant appears to be associated with improved treatment outcomes in Asian CML patients, the mechanism of this association is unknown.